Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013802 220019830 null 65.2 Curative (C) 2014-04-26 2015-06-28 Dasatinib N null 220031258 DASATINIB
220013803 220008225 1.87 null Curative (C) 2016-07-27 2016-10-23 Alemtuz+Fludara+Melphalan RIC MUD 02 null 220031271 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013804 220014484 1.8 null Palliative (P) 2013-11-19 2013-11-19 Dasatinib 02 N 220031273 DASATINIB
220013805 220014484 null 74 Disease modification (D) 2014-09-29 2014-11-26 AML18 PILOT TRIAL 01 N 220031273 PILOT TRIAL
220013807 220008230 1.62 0 Neo-adjuvant (N) 2014-09-07 2014-09-07 Dasatinib N N 220031279 DASATINIB
220013808 220008231 1.6 null Palliative (P) 2014-01-09 2014-01-12 Dasatinib 2 N 220031285 DASATINIB
220013809 220008231 1.6 null Curative (C) 2015-03-20 2015-04-26 Rituximab N N 220031285 RITUXIMAB
220013810 220008233 1.61 58.5 Curative (C) 2016-05-30 2016-05-30 AML 18 TRIAL Y N 220031294 AML18 TRIAL
220013811 220008234 null 79.2 Curative (C) 2017-04-21 2017-05-07 Alemtuz+Fludara+Melphalan RIC MUD N N 220031298 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013812 220008235 1.31 68.5 Disease modification (D) 2015-08-25 2015-08-25 Rituximab N N 220031299 RITUXIMAB
220013814 220008239 1.65 76 T 2014-06-07 2014-06-11 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220031302 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013815 220022102 1.7 78.8 Curative (C) 2014-05-05 2014-05-08 Rituximab null N 220031303 RITUXIMAB
220013816 220022102 1.59 74.4 Curative (C) 2017-08-09 2017-08-17 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220031303 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013817 220008242 null 65.4 Disease modification (D) 2014-08-02 2014-09-03 AML18 PILOT TRIAL N null 220031309 PILOT TRIAL
220013818 220008243 1.75 65.7 Disease modification (D) 2017-09-24 2017-12-12 Rituximab N null 220031309 RITUXIMAB
220013819 220008243 1.73 0 Palliative (P) 2016-08-17 2016-08-20 Dasatinib 01 N 220031309 DASATINIB
220013820 220008243 1.69 73.4 Curative (C) 2017-05-12 2017-08-31 AML18 PILOT TRIAL Y Y 220031309 PILOT TRIAL
220013821 220020938 1.62 62 Curative (C) 2017-04-04 2017-05-29 AML18 PILOT TRIAL Y N 220031331 PILOT TRIAL
220013822 220008244 1.67 88.7 Curative (C) 2015-09-25 2015-11-02 AML 18 TRIAL Y N 220031337 AML18 TRIAL
220013823 220008245 null 75 Curative (C) 2017-12-16 2017-12-24 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220031338 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013824 220008246 1.58 44.7 null 2017-01-12 2017-01-19 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 02 null 220031339 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013825 220008247 null 111.2 Disease modification (D) 2014-01-10 2014-06-06 AML 18 TRIAL 1 N 220031344 AML18 TRIAL
220013826 220017916 1.6 null Curative (C) 2015-12-30 2016-01-03 Dasatinib N null 220031347 DASATINIB
220013827 220017916 0 53.7 Curative (C) 2014-01-09 2014-01-09 Dasatinib 02 N 220031347 DASATINIB
220013828 220014493 1.69 92 Curative (C) 2016-04-19 2016-04-23 Rituximab N N 220031352 RITUXIMAB
220013829 220008249 1.7 84 Curative (C) 2014-02-14 2014-02-21 Alemtuz+Fludara+Melphalan RIC MUD Y N 220031359 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013830 220008249 null null Curative (C) 2017-02-20 2017-03-03 Alemtuz+Fludara+Melphalan RIC MUD N N 220031359 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013831 220008249 1.61 81 Curative (C) 2012-02-17 2013-03-31 Dasatinib 99 N 220031359 DASATINIB
220013832 220008249 null 110 Curative (C) null 2016-03-25 AML 18 TRIAL Y null 220031359 AML18 TRIAL
220013833 220008250 null 96 Curative (C) 2014-04-13 2015-08-23 Dasatinib 99 N 220031392 DASATINIB
220013834 220008256 1.81 73.4 null 2016-08-02 2016-08-03 AML18 PILOT TRIAL N null 220031393 PILOT TRIAL
220013835 220008257 1.84 87 Curative (C) 2013-06-05 2013-06-10 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220031395 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013836 220008258 1.83 80.85 Disease modification (D) 2015-05-19 2015-12-16 Rituximab N N 220031398 RITUXIMAB
220013837 220008258 1.83 96 Curative (C) 2016-03-06 2016-05-27 AML18 PILOT TRIAL 1 N 220031398 PILOT TRIAL
220013839 220008262 1.64 58 Disease modification (D) 2014-07-09 2014-07-30 AML 18 TRIAL 1 N 220031403 AML18 TRIAL
220013840 220008262 1.72 83.3 Curative (C) 2017-01-27 2017-04-21 Dasatinib N N 220031403 DASATINIB
220013841 220014501 1.72 67.2 Curative (C) 2015-09-23 2015-11-04 AML18 PILOT TRIAL null N 220031416 PILOT TRIAL
220013842 220017922 1.69 null Curative (C) 2017-12-27 2018-01-10 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220031416 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013843 220008269 1.74 null Palliative (P) 2016-11-11 2016-11-12 Dasatinib 2 N 220031434 DASATINIB
220013844 220008269 1.72 null Palliative (P) 2014-04-01 2014-04-01 Dasatinib N N 220031434 DASATINIB
220013845 220008273 1.8 0 Disease modification (D) 2017-07-17 2017-07-21 Rituximab N N 220031440 RITUXIMAB
220013846 220014503 1.79 82.6 Curative (C) 2015-08-21 2015-08-21 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220031441 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013847 220014504 1.78 96 Curative (C) 2013-12-30 2013-12-30 Alemtuz+Fludara+Melphalan RIC MUD null N 220031449 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013848 220008275 1.84 0 Palliative (P) null 2014-04-30 Dasatinib 02 N 220031455 DASATINIB
220013849 220008278 null 0 Curative (C) 2015-02-18 2015-02-21 Dasatinib N null 220031465 DASATINIB
220013850 220008279 1.81 138 Curative (C) 2014-06-25 2014-10-30 Dasatinib N null 220031468 DASATINIB
220013856 220008281 1.63 0 Palliative (P) 2016-09-14 2016-09-14 Dasatinib 2 N 220031479 DASATINIB
220013857 220008283 1.54 70 Curative (C) 2014-08-12 2014-08-14 Rituximab (Maintenance) N N 220031482 RITUXIMAB
220013858 220008285 1.56 80.6 Disease modification (D) 2013-11-13 2013-11-21 ALEMTUZUMAB + FLUDARABINE + MELPHALAN null N 220031491 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013859 220014508 1.75 80.9 Curative (C) 2016-12-29 2017-04-18 AML18 PILOT TRIAL N N 220031493 PILOT TRIAL